During the past decade, Queens Cancer Center of Queens Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 11 clinical trials were completed, i.e. on average, 275% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queens Cancer Center of Queens Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 34 trials, followed by "Memorial Sloan Kettering Cancer Center" with 12 trials sponsored, "NSABP Foundation Inc" with 4 trials sponsored, "Accelerated Community Oncology Research Network" with 1 trials sponsored and "Cancer and Leukemia Group B" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queens Cancer Center of Queens Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 44 trials as a collaborator, "Queens Cancer Center of Queens Hospital" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "Queens Health Network" with 3 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Queens Cancer Center of Queens Hospital" are "Breast Cancer" (13 trials), "Lung Cancer" (11 trials), "Colorectal Cancer" (7 trials), "Leukemia" (6 trials) and "Lymphoma" (6 trials). Many other conditions were trialed in "Queens Cancer Center of Queens Hospital" in a lesser frequency.

Most popular intervention types in "Queens Cancer Center of Queens Hospital" are "Drug" (38 trials), "Other" (8 trials), "Biological" (7 trials), "Procedure" (7 trials) and "Behavioral" (6 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (6 trials), "gemcitabine hydrochloride" (6 trials), "carboplatin" (4 trials), "cisplatin" (4 trials) and "docetaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Queens Cancer Center of Queens Hospital" are 43 trials for "All" genders, 10 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Queens Cancer Center of Queens Hospital". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 45 completed trials in Queens Cancer Center of Queens Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Queens Cancer Center of Queens Hospital, 2 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".